Advertisement

Reactions Weekly

, Volume 1722, Issue 1, pp 18–18 | Cite as

Afatinib

Various toxicities: 4 case reports
Case report
  • 13 Downloads

Reference

  1. Miyazaki K, et al. Real clinical practice of using afatinib therapy in NSCLC patients with an acquired EGFR T790M mutation. Anticancer Research 38: 5409-5415, No. 9, Sep 2018. Available from: URL: http://doi.org/10.21873/anticanres.12871 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations